Children with chronic myeloid leukaemia treated with front-line imatinib have a slower molecular response and comparable survival compared with adults: a multicenter experience in Taiwan
台湾一项多中心研究发现,接受一线伊马替尼治疗的慢性粒细胞白血病患儿,其分子学缓解速度较慢,但生存期与成人相当:
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-023-02162-9
Liu, Hsi-Che; Kuo, Ming-Chung; Wu, Kang-Hsi; Chen, Tsai-Yun; Chen, Jiann-Shiuh; Wang, Ming-Chung; Lin, Tung-Liang; Yang, YoungSen; Ma, Ming-Chun; Wang, Po-Nan; Sheen, Jiunn-Ming; Wang, Shih-Chung; Chen, Shih-Hsiang; Jaing, Tang-Her; Cheng, Chao-Neng; Yeh, Ting-Chi; Lin, Tung-Huei; Shih, Lee-Yung